SLEB3
MCID: SYS046
MIFTS: 18

Systemic Lupus Erythematosus 3 (SLEB3)

Categories: Bone diseases, Genetic diseases, Immune diseases, Nephrological diseases, Rare diseases, Skin diseases

Aliases & Classifications for Systemic Lupus Erythematosus 3

MalaCards integrated aliases for Systemic Lupus Erythematosus 3:

Name: Systemic Lupus Erythematosus 3 57
Systemic Lupus Erythematosus, Susceptibility to, 3 57 13
Sleb3 57

Classifications:



External Ids:

OMIM® 57 605480
MedGen 41 C1854235

Summaries for Systemic Lupus Erythematosus 3

MalaCards based summary : Systemic Lupus Erythematosus 3, also known as systemic lupus erythematosus, susceptibility to, 3, is related to systemic lupus erythematosus and autoimmune disease. An important gene associated with Systemic Lupus Erythematosus 3 is SLEB3 (Systemic Lupus Erythematosus Susceptibility 3). Affiliated tissues include bone, kidney and liver.

More information from OMIM: 605480

Related Diseases for Systemic Lupus Erythematosus 3

Symptoms & Phenotypes for Systemic Lupus Erythematosus 3

Clinical features from OMIM®:

605480 (Updated 05-Apr-2021)

Drugs & Therapeutics for Systemic Lupus Erythematosus 3

Search Clinical Trials , NIH Clinical Center for Systemic Lupus Erythematosus 3

Genetic Tests for Systemic Lupus Erythematosus 3

Anatomical Context for Systemic Lupus Erythematosus 3

MalaCards organs/tissues related to Systemic Lupus Erythematosus 3:

40
Bone, Kidney, Liver, Endothelial

Publications for Systemic Lupus Erythematosus 3

Articles related to Systemic Lupus Erythematosus 3:

(show all 46)
# Title Authors PMID Year
1
Localization and replication of the systemic lupus erythematosus linkage signal at 4p16: interaction with 2p11, 12q24 and 19q13 in European Americans. 57
16983533 2007
2
SLEB3 in systemic lupus erythematosus (SLE) is strongly related to SLE families ascertained through neuropsychiatric manifestations. 57
12136236 2002
3
Genome scan of human systemic lupus erythematosus by regression modeling: evidence of linkage and epistasis at 4p16-15.2. 57
11078476 2000
4
[Immune disorders associated with juvenile recurrent chronic parotitis]. 61
33008791 2020
5
Etiologies and Treatment Burden in Adult Patients with Pure Red Cell Aplasia: A Single-Center Experience and Review of Literature. 61
32257434 2020
6
Frontal fibrosing alopecia demographics: a survey of 29 patients. 61
30893399 2019
7
Bamboo Nodes of Vocal Folds: A Description of 10 Cases and Review of the Literature. 61
29847817 2018
8
[The function and the significance of full-automated tests for detecting antiphospholipid antibodies]. 61
26213194 2015
9
Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients. 61
25274898 2014
10
A study on oral mucosal lesions in 3500 patients with dermatological diseases in South India. 61
25184094 2014
11
The implication of vitamin D and autoimmunity: a comprehensive review. 61
23359064 2013
12
A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 1. 61
23205324 2012
13
Pleuropulmonary pathology in patients with rheumatic disease. 61
23020730 2012
14
Atypical lymphoplasmacytic and immunoblastic proliferation of autoimmune disease : clinicopathologic and immunohistochemical study of 9 cases. 61
21123969 2010
15
Kidney transplantation during autoimmune diseases. 61
19765434 2009
16
Proliferation signal inhibitors for the treatment of refractory autoimmune rheumatic diseases: a new therapeutic option. 61
19758225 2009
17
Neutrophilic urticarial dermatosis: a variant of neutrophilic urticaria strongly associated with systemic disease. Report of 9 new cases and review of the literature. 61
19352297 2009
18
Pregnancy outcome in lupus nephropathy. 61
15052490 2005
19
Low frequency of anti-SLA/LP autoantibody in Japanese adult patients with autoimmune liver diseases: analysis with recombinant antigen assay. 61
12892738 2003
20
Changes in lymphocytic cluster distribution during extracorporeal immunoadsorption. 61
11879242 2002
21
Autoimmune lymphoproliferative syndrome, a disorder of apoptosis. 61
10590910 1999
22
Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR). 61
10507481 1999
23
Clinical presentation and disease associations of gout: a hospital-based study of 100 patients in Singapore. 61
9588267 1998
24
Increased serum levels of soluble CD44-isoform v5 in rheumatic diseases are restricted to seropositive rheumatoid arthritis. 61
9150806 1997
25
Clinical significance of complements in ascitic diseases: elevated complement levels disapproving the liver disease origin. 61
8931344 1996
26
Modifications of biochemical markers of bone and collagen turnover during corticosteroid therapy. 61
8778165 1996
27
Determinants of survival in pediatric continuous hemofiltration. 61
8589315 1995
28
Use of antineutrophil cytoplasmic autoantibodies in diagnosing vasculitis in a Chinese patient population. 61
7915885 1994
29
T and B cell immune response to a 55-kDa endothelial cell-derived antigen in severe asthma. 61
8458370 1993
30
Use of anti-thymocyte globulin in the management of refractory systemic autoimmune diseases. 61
8266027 1993
31
[Internal ear dysfunction in systemic autoimmune diseases: study of sensorineural hearing loss probably originated by autoimmune disorders (preliminary study)]. 61
2268458 1990
32
Depressed plasma fibrinolytic activity in a group of patients with connective tissue diseases. 61
2512638 1989
33
[Lip ulceration disclosing systemic lupus erythematosus: 3 cases]. 61
2619176 1989
34
Venous thrombosis associated with lupus anticoagulant and anticardiolipin antibodies. 61
3144118 1988
35
Occurrence of Kawasaki disease and systemic lupus erythematosus in a single patient. 61
3379628 1988
36
Studies of macrophage function in murine systemic lupus erythematosus. 3. The nature, anatomical location, and reversibility of the phagocytic defect. 61
3455711 1986
37
Antikeratin antibodies in serum and synovial fluid show specificity for rheumatoid arthritis in a study of connective tissue diseases. 61
2411231 1985
38
[Effect of the method of extracorporeal heparin precipitation of plasma proteins (selective plasmapheresis) on the level of immune complexes in the blood]. 61
2931844 1985
39
Urinary bladder tumors following cyclophosphamide therapy: a report of two cases with a review of the literature. 61
3982369 1985
40
Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum. 61
6418767 1984
41
[Nursing of patients with systemic lupus erythematosus. 3]. 61
6901940 1980
42
Early pleural decortication for thoracic empyema in immunosuppressed patients. 61
904351 1977
43
Immunoglobulin E in renal disease. 61
55986 1976
44
Systemic lupus erythematosus and spontaneously arising anticoagulants. 61
1188558 1975
45
Laboratory tests for diagnosis of autoimmune diseases. 61
1105671 1975
46
Family studies in systemic lupus erythematosus. 3. Presence of LE factor in relatives and spouses. 61
4124130 1972

Variations for Systemic Lupus Erythematosus 3

Expression for Systemic Lupus Erythematosus 3

Search GEO for disease gene expression data for Systemic Lupus Erythematosus 3.

Pathways for Systemic Lupus Erythematosus 3

GO Terms for Systemic Lupus Erythematosus 3

Sources for Systemic Lupus Erythematosus 3

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 05-Apr-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 Tocris
70 UMLS
71 UMLS via Orphanet
Content
Loading form....